Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Medicina (Kaunas, Lithuania) - 10 Mar 2026

Quacoe Andrew E, Freiberger Sandra N, Levesque Mitchell P, Dummer Reinhard, Ramelyte Egle

Abstract excerpt

Background and Objectives: Melanoma is the leading cause of skin cancer-related mortality due to its high propensity for early metastasis, although survival rates have improved with the advent of targeted and immune-based therapies. Accurate detection of targetable mutations and assessment of tumor mutational burden are essential for informed therapeutic decision-making. Mutation profiling is routinely performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Melanoma

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41901593
DOI: 10.3390/medicina62030510
PMCID: PMC13027622

Genes

BRAF
CDKN2A
TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.PMID 41901593Read ↗

Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain.Semantic proximity Read ↗

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.Semantic proximity Read ↗

Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.Semantic proximity Read ↗

The genomic landscape of cutaneous melanomaSemantic proximity Read ↗

Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive AlterationsSemantic proximity Read ↗

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy PredictionSemantic proximity Read ↗

Melanoma genomics: a state-of-the-art review of practical clinical applications.Semantic proximity Read ↗

Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing PanelSemantic proximity Read ↗

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.Semantic proximity Read ↗

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.Semantic proximity Read ↗

Medical bioinformatics in melanomaSemantic proximity Read ↗

A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.